Analystreport

Reata Pharmaceuticals, Inc. (NASDAQ: RETA) is now covered by analysts at Jefferies Group LLC. They set a "buy" rating on the stock.

Reata Pharmaceuticals, Inc. - Class A  (RETA) 
Last reata pharmaceuticals, inc. - class a earnings: 2/19 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.reatapharma.com